MedTrace Logo

Coenzyme q 10 and Fertility Outcome in Women With Clomiphene Resistant PCOS

NCT04302532 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2020-11-25

No results posted yet for this study

Summary

The study evaluates the effect of coenzyme q 10 on ovulation and subsequent pregnancy in women with polycystic ovarian syndrome. Half of the participants will receive coq10 and ovulation induction with clomiphene and other half would receive a placebo with clomiphene.

Conditions

  • Coenzyme q10

Interventions

DRUG

Coenzyme Q10

antioxidant used to decrease oxidative stress and improve fertility prospects

DRUG

clomiphene citrate

ovulation induction drug

Sponsors & Collaborators

  • Karachi Medical and Dental College

    lead OTHER

Principal Investigators

  • Rubina Izhar · Aziz Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-09-30
Completion
2020-10-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04302532 on ClinicalTrials.gov